Cargando…

How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis

BACKGROUND: Adverse drug reactions (ADRs) are a well-recognized public health problem and a major cause of death and hospitalization in developed countries. The safety of a new drug cannot be established until it has been on the market for several years. Keeping drug reactions under surveillance thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro-Vaz, Inês, Silva, Ana-Marta, Costa Santos, Cristina, Cruz-Correia, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772685/
https://www.ncbi.nlm.nih.gov/pubmed/26926375
http://dx.doi.org/10.1186/s12911-016-0265-8
_version_ 1782418614472671232
author Ribeiro-Vaz, Inês
Silva, Ana-Marta
Costa Santos, Cristina
Cruz-Correia, Ricardo
author_facet Ribeiro-Vaz, Inês
Silva, Ana-Marta
Costa Santos, Cristina
Cruz-Correia, Ricardo
author_sort Ribeiro-Vaz, Inês
collection PubMed
description BACKGROUND: Adverse drug reactions (ADRs) are a well-recognized public health problem and a major cause of death and hospitalization in developed countries. The safety of a new drug cannot be established until it has been on the market for several years. Keeping drug reactions under surveillance through pharmacovigilance systems is indispensable. However, underreporting is a major issue that undermines the effectiveness of spontaneous reports. Our work presents a systematic review on the use of information systems for the promotion of ADR reporting. The aim of this work is to describe the state of the art information systems used to promote adverse drug reaction reporting. METHODS: A systematic review was performed with quantitative analysis of studies describing or evaluating the use of information systems to promote adverse drug reaction reporting. Studies with data related to the number of ADRs reported before and after each intervention and the follow-up period were included in the quantitative analysis. RESULTS: From a total of 3865 articles, 33 articles were included in the analysis; these articles described 29 different projects. Most of the projects were on a regional scale (62 %) and were performed in a hospital context (52 %). A total of 76 % performed passive promotion of ADR reporting and used web-based software (55 %). A total of 72 % targeted healthcare professionals and 24 % were oriented to patient ADR reporting. We performed a meta-analysis of 7 of the 29 projects to calculate the aggregated measure of the ADR reporting increase, which had an overall measure of 2.1 (indicating that the interventions doubled the number of ADRs reported). CONCLUSIONS: We found that most of the projects performed passive promotion of ADR reporting (i.e., facilitating the process). They were developed in hospitals and were tailored to healthcare professionals. These interventions doubled the number of ADR reports. We believe that it would be useful to develop systems to assist healthcare professionals with completing ADR reporting within electronic health records because this approach seems to be an efficient method to increase the ADR reporting rate. When this approach is not possible, it is essential to have a tool that is easily accessible on the web to report ADRs. This tool can be promoted by sending emails or through the inclusion of direct hyperlinks on healthcare professionals’ desktops.
format Online
Article
Text
id pubmed-4772685
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47726852016-03-02 How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis Ribeiro-Vaz, Inês Silva, Ana-Marta Costa Santos, Cristina Cruz-Correia, Ricardo BMC Med Inform Decis Mak Research Article BACKGROUND: Adverse drug reactions (ADRs) are a well-recognized public health problem and a major cause of death and hospitalization in developed countries. The safety of a new drug cannot be established until it has been on the market for several years. Keeping drug reactions under surveillance through pharmacovigilance systems is indispensable. However, underreporting is a major issue that undermines the effectiveness of spontaneous reports. Our work presents a systematic review on the use of information systems for the promotion of ADR reporting. The aim of this work is to describe the state of the art information systems used to promote adverse drug reaction reporting. METHODS: A systematic review was performed with quantitative analysis of studies describing or evaluating the use of information systems to promote adverse drug reaction reporting. Studies with data related to the number of ADRs reported before and after each intervention and the follow-up period were included in the quantitative analysis. RESULTS: From a total of 3865 articles, 33 articles were included in the analysis; these articles described 29 different projects. Most of the projects were on a regional scale (62 %) and were performed in a hospital context (52 %). A total of 76 % performed passive promotion of ADR reporting and used web-based software (55 %). A total of 72 % targeted healthcare professionals and 24 % were oriented to patient ADR reporting. We performed a meta-analysis of 7 of the 29 projects to calculate the aggregated measure of the ADR reporting increase, which had an overall measure of 2.1 (indicating that the interventions doubled the number of ADRs reported). CONCLUSIONS: We found that most of the projects performed passive promotion of ADR reporting (i.e., facilitating the process). They were developed in hospitals and were tailored to healthcare professionals. These interventions doubled the number of ADR reports. We believe that it would be useful to develop systems to assist healthcare professionals with completing ADR reporting within electronic health records because this approach seems to be an efficient method to increase the ADR reporting rate. When this approach is not possible, it is essential to have a tool that is easily accessible on the web to report ADRs. This tool can be promoted by sending emails or through the inclusion of direct hyperlinks on healthcare professionals’ desktops. BioMed Central 2016-03-01 /pmc/articles/PMC4772685/ /pubmed/26926375 http://dx.doi.org/10.1186/s12911-016-0265-8 Text en © Ribeiro-Vaz et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ribeiro-Vaz, Inês
Silva, Ana-Marta
Costa Santos, Cristina
Cruz-Correia, Ricardo
How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
title How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
title_full How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
title_fullStr How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
title_full_unstemmed How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
title_short How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
title_sort how to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772685/
https://www.ncbi.nlm.nih.gov/pubmed/26926375
http://dx.doi.org/10.1186/s12911-016-0265-8
work_keys_str_mv AT ribeirovazines howtopromoteadversedrugreactionreportsusinginformationsystemsasystematicreviewandmetaanalysis
AT silvaanamarta howtopromoteadversedrugreactionreportsusinginformationsystemsasystematicreviewandmetaanalysis
AT costasantoscristina howtopromoteadversedrugreactionreportsusinginformationsystemsasystematicreviewandmetaanalysis
AT cruzcorreiaricardo howtopromoteadversedrugreactionreportsusinginformationsystemsasystematicreviewandmetaanalysis